Arrhythmic expression signatures of circadian clock‐associated transcription factors and chronic circadian disruption contribute to advanced prostate cancer growth

Documenti analoghi

• Training and validation of a novel 14‐gene expression signature associated with prostate cancer metastasis and postoperative recurrence
  di: Eva F. Jensby, et al.
  Pubblicazione: (2025)
• Top advances of the year: Radiopharmaceutical therapy for prostate cancer
  di: Valentina Marulanda‐Corzo, et al.
  Pubblicazione: (2026)
• Mutational signatures and their association with cancer survival and gene expression in multiple cancer types
  di: Peeter Karihtala, et al.
  Pubblicazione: (2024)
• Gut microbiota is associated with circadian rhythms and clock gene expression in honeybees
  di: Yueyi Wang, et al.
  Pubblicazione: (2026)
• The 340B Program and oral specialty drugs for advanced prostate cancer
  di: Kassem S. Faraj, et al.
  Pubblicazione: (2024)